| Dr Carlan Gordon, PSYD | |
|
2211 Rimland Dr Ste 320, Bellingham, WA 98226-6014 | |
| (360) 752-5175 | |
| Not Available |
| Full Name | Dr Carlan Gordon |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 2211 Rimland Dr Ste 320, Bellingham, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528419785 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY.0004884 (Colorado) | Secondary |
| 103TC0700X | Psychologist - Clinical | 61277804 (Washington) | Primary |
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309553 PECOS PAC ID: 9537073960 Enrollment ID: O20031118001062 |
News Archive
Reconciliation, a parliamentary tactic that could allow Congress to pass health reform with a simple Senate majority, was dismissed weeks ago by centrist Democrats, but some of those lawmakers are now warming to the approach, clearing a possible avenue for passage of the overhaul, Politico reports. "Obviously, if the minority is just frustrating the process, that argues for taking steps to get the public's business done," said Sen. Evan Bayh, D-Ind., one of the senators to reverse course on reconciliation (Budoff Brown, 2/23).
The new sporting craze of 'Walking Football' may enable people to continue playing football into their 60s and 70s while reaping a multitude of health benefits, according to Aston University researchers.
ScinoPharm announced today that its Tainan, Taiwan Facility will provide commercial manufacturing of topiramate active pharmaceutical ingredient ("API") for VIVUS' Qsymia, a new drug for the treatment of obesity approved by the United States Food and Drug Administration on July 17, 2012.
Biophysicists have developed a hypothesis to explain the function of a light-driven protein which pumps sodium ions across a cell membrane, and they have revealed the key structural feature of these pumps. The scientists see these sodium pumps as being highly promising tools in using light signals to control nerve cells – which is exactly what is involved in the new scientific field of optogenetics.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carlan Gordon, PSYD 2211 Rimland Dr Ste 320, Bellingham, WA 98226-6014 Ph: (360) 752-5175 | Dr Carlan Gordon, PSYD 2211 Rimland Dr Ste 320, Bellingham, WA 98226-6014 Ph: (360) 752-5175 |
News Archive
Reconciliation, a parliamentary tactic that could allow Congress to pass health reform with a simple Senate majority, was dismissed weeks ago by centrist Democrats, but some of those lawmakers are now warming to the approach, clearing a possible avenue for passage of the overhaul, Politico reports. "Obviously, if the minority is just frustrating the process, that argues for taking steps to get the public's business done," said Sen. Evan Bayh, D-Ind., one of the senators to reverse course on reconciliation (Budoff Brown, 2/23).
The new sporting craze of 'Walking Football' may enable people to continue playing football into their 60s and 70s while reaping a multitude of health benefits, according to Aston University researchers.
ScinoPharm announced today that its Tainan, Taiwan Facility will provide commercial manufacturing of topiramate active pharmaceutical ingredient ("API") for VIVUS' Qsymia, a new drug for the treatment of obesity approved by the United States Food and Drug Administration on July 17, 2012.
Biophysicists have developed a hypothesis to explain the function of a light-driven protein which pumps sodium ions across a cell membrane, and they have revealed the key structural feature of these pumps. The scientists see these sodium pumps as being highly promising tools in using light signals to control nerve cells – which is exactly what is involved in the new scientific field of optogenetics.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
› Verified 1 days ago
Patricia A Marek, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1201 11th Street Suite 201, Bellingham, WA 98225 Phone: 360-647-2808 Fax: 360-752-0037 | |
Dr. Steve Call, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 801 Samish Way, Bellingham, WA 98229 Phone: 425-753-3547 | |
Kathryn Oost, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1140 10th St Ste 203, Bellingham, WA 98225 Phone: 360-603-0518 | |
Nahid Markosian, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 12 Bellwether Way, Suite 223, Bellingham, WA 98225 Phone: 360-255-2505 Fax: 360-255-2504 | |
Dr. Thomas Christopher Portman, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1118 Finnegan Way, Suite 104, Bellingham, WA 98225 Phone: 360-733-4502 Fax: 360-733-7594 | |
Dr. Cara Joann Anderson, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1155 N State St, Bellingham, WA 98225 Phone: 360-255-2505 Fax: 360-255-2504 | |
Dr. Susan D. Kane-ronning, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1117 Ellis St, Bellingham, WA 98225 Phone: 360-714-8109 Fax: 360-756-8936 |